综合转录组学和实验验证显示,酸可通过PLAU/NF-κB信号传递缓解Fuchs内皮角膜缩症
Tianyi Zhou1,2, Jiaming Sun3, Wenjun Shi3
1Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Investigative ophthalmology & visual science
|January 14, 2026
概括
埃拉基酸 (EA) 通过向尿素激酶类型等离子激素激活剂 (PLAU) 和NF-κB信号来减少福克斯内皮角膜变 (FECD) 中的氧化应激和炎症. 这突出了EA和PLAU作为角膜疾病的潜在治疗方法.
科学领域:
- 眼科医生 眼科 眼科
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 福克斯内皮角膜缩症 (FECD) 具有氧化应激和炎症的特征.
- 目前对FECD的治疗策略有限,需要新的干预措施.
- 埃拉基酸 (EA) 是一种天然的多,具有抗氧化和抗炎性质.
研究的目的:
- 调查基酸 (EA) 在减轻FECD中氧化应激和炎症中的作用.
- 评估EA的治疗潜力,通过检查其对尿激酶类型等离子体激活剂 (PLAU) 和NF-κB信号通路的影响.
- 在FECD的背景下,确定EA行动中涉及的关键分子目标和途径.
主要方法:
- 综合生物信息学分析以确定EA目标基因和与FECD相关的差异表达基因 (DEG).
- 使用受氧化和炎症刺激的人类角膜内皮细胞 (CEC) 的实验验验证.
- 采用分子对接,ROC分析,免疫透分析和siRNA介导的敲击来确认目标和途径.
主要成果:
- 确定了EA目标和FECD DEG之间的21个重叠基因,其中PLAU成为一个关键的枢纽基因.
- 功能丰富分析将枢纽基因与NF-κB信号传递,炎症和氧化应激途径联系起来.
- 通过向PLAU和调节NF-κB信号,EA治疗证明了CEC的炎症和氧化损伤的减弱.
结论:
- 在FECD模型中,酸有效地减轻氧化应激和炎症.
- EA通过准PLAU和调节NF-κB信号来发挥其治疗作用.
- 在角膜内皮细胞疾病中,EA和PLAU是新型干预措施的有希望的治疗点.
更多相关视频
12:36A Human Corneal Organ Culture Model of Descemet's Stripping Only with Accelerated Healing Stimulated by Engineered Fibroblast Growth Factor 1
Published on: July 22, 2022
5.0K
08:20Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model
Published on: December 2, 2022
2.2K
相关概念视频
NF-κB-dependent Signaling Pathway
9.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.8K
iPS Cell Differentiation
3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
